Johnson &amp; Johnson Q2 $JNJ:
Adjusted EPS $2.48, Est. $2.29, boosts FY forecast.
Worldwide Covid vaccine sales $164m (+64% QoQ).
Total sales $23.31b, Est. $22.54b.
Worldwide medical device sales $6.98b, Est. $6.59b.
  